Policy Notices

• AHRQ Announces Interest in Primary Care Research
  (NOT-HS-22-011)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of NCCIH Technical Assistance Webinar for RFA-AT-22-001, "NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
  (NOT-AT-22-016)
  National Center for Complementary and Integrative Health
  

• NIDA Challenge "CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and portable cause of death detection technologies to improve drug overdose-related mortality counts"
  (NOT-DA-22-054)
  National Institute on Drug Abuse
  

• Findings of Research Misconduct
  (NOT-OD-22-095)
  Office of the Director, NIH
  

• Findings of Research Misconduct
  (NOT-OD-22-096)
  Office of the Director, NIH
  

• Findings of Research Misconduct
  (NOT-OD-22-097)
  Office of the Director, NIH
  

• Findings of Research Misconduct
  (NOT-OD-22-098)
  Office of the Director, NIH
  

• Request for Information (RFI): Inviting comments to inform the National Institutes of Health (NIH) on the intersection of the SARS-CoV-2/COVID-19 pandemic and the health of women
  (NOT-OD-22-092)
  Office of Research on Women's Health
  

• Request for Information (RFI): Challenges and Opportunities in Elucidating the Human Virome
  (NOT-RM-22-010)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of Cancellation of RFA-DK-22-005, Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
  (NOT-DK-22-019)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change to update Eligibility Information under RFA-FD-22-010; "Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18)"
  (NOT-FD-22-009)
  Food and Drug Administration
  

• Notice of Correction to Eligibility and Application Types in RFA-HL-23-006, " Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
  (NOT-HL-22-013)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to PAR-21-357 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
  (NOT-NS-22-075)
  National Institute of Neurological Disorders and Stroke
  

• Notice to Extend Expiration Date for PAR-20-128: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
  (NOT-OD-22-085)
  Office of the Director, NIH
  

• Notice to Extend Expiration Date for PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
  (NOT-OD-22-086)
  Office of the Director, NIH
  

• Notice to Extend Expiration Date for PAR-20-130: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
  (NOT-OD-22-087)
  Office of the Director, NIH
  

• Notice of Change to RFA-OD-22-004, Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
  (NOT-OD-22-094)
  Office of Disease Prevention
  

• Notice of Change to Correct Eligibility Information under RFA-RM-22-008; "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)"
  (NOT-RM-22-011)
  Office of Strategic Coordination (Common Fund)
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for An Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
  (NOT-HG-22-012)
  National Human Genome Research Institute
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data.
  (NOT-CA-22-056)
  National Cancer Institute
  National Institute of Environmental Health Sciences
  

• Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
  (NOT-TR-22-023)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
  (PAR-22-133)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIAID Research Education Program (R25 Clinical Trial Not Allowed)
  (PAR-22-134)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
  (PAR-22-137)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2025
  
  

• Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
  (PAR-22-138)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2025
  
  

• Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
  (PAR-22-139)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
  (PAR-22-140)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
  (PAR-22-141)
  National Eye Institute
  Application Receipt Date(s): May 07, 2025
  
  

• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)
  (RFA-DA-23-004)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 11, 2022
  
  

• Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)
  (RFA-DA-23-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 15, 2022
  
  

• Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional)
  (RFA-DA-23-010)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 15, 2022
  
  

• KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
  (RFA-DK-21-033)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 01, 2025
  
  

• NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)
  (RFA-DK-22-004)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): June 21, 2022
  
  

• National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)
  (RFA-HD-23-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 28, 2022
  
  

• Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
  (RFA-HL-23-007)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 12, 2022; October 12, 2023; October 12, 2024,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed)
  (RFA-LM-22-001)
  National Library of Medicine
  Application Receipt Date(s): May 31, 2022